Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: Results of a phase II trial

Anne H. Blaes, Bruce A. Peterson, Nancy Bartlett, David L. Dunn, Vicki A. Morrison

Research output: Contribution to journalArticlepeer-review

107 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: Results of a phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences